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  A b s t r a c t
   Background:  The ‘drip-and-ship’ paradigm denotes a treatment regimen in patients in whom 
intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is initiated at the emergency 
department (ED) of a community hospital, followed by transfer within 24 h to a comprehensive 
stroke center. Although the drip-and-ship paradigm has the potential to increase the number 
of patients who receive IV rt-PA, comparative outcomes have not been assessed at a popula-
tion-based level.   Methods:  Statewide estimates of thrombolysis, associated in-hospital out-
comes, and hospitalization charges were obtained from 2008–2009 Minnesota Hospital Asso-
ciation data for all patients hospitalized with a primary diagnosis of ischemic stroke. Patients 
who were assigned the drip-and-ship code [International Classification of Diseases, 9th revision, 
Clinical Modification (ICD-9-CM) V45.88] were classified under the drip-and-ship paradigm. Pa-
tients who underwent thrombolysis (ICD-9-CM code 99.10) without drip-and-ship code were 
classified as primary ED arrival. Patient outcomes were analyzed after stratification into patients 
treated with IV rt-PA through primary ED arrival or drip-and-ship paradigm.   Results:  Of the 
21,024 admissions, 602 (2.86%) received IV rt-PA either through primary ED arrival (n = 473) or 
the drip-and-ship paradigm (n = 129). IV rt-PA was administered in 30 hospitals, of which 13 hos-
pitals used the drip-and-ship paradigm; the number of patients treated with the drip-and-ship 
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paradigm varied from 1 to 40 between the 13 hospitals. The rates of secondary intracerebral or 
subarachnoid hemorrhage were higher in patients treated with IV rt-PA through primary ED ar-
rival compared with those treated with the drip-and-ship paradigm (8.5 vs. 3.1%, respectively; 
p = 0.038). The in-hospital mortality rate was similar among ischemic stroke patients receiving 
IV rt-PA through primary ED arrival or the drip-and-ship paradigm (5.9 vs. 7.0%, respectively). 
The mean hospital charges were USD 65,669 for primary ED arrival and USD 47,850 for drip-and-
ship-treated patients (p   !   0.001). The rate of admission to a certified stroke center as final des-
tination for acute hospitalization was higher in patients treated by drip-and-ship paradigm 
compared with those treated by primary ED arrival mode (p = 0.015).   Conclusions:  The results 
of the drip-and-ship paradigm compare favorably with IV rt-PA treatment through primary ED 
arrival in this statewide study. Our results support the recommendations of various profession-
al organizations that the drip-and-ship method of IV rt-PA administration for stroke may be an 
effective option for increasing the utilization of IV rt-PA on a large scale.
    Copyright © 2012 S. Karger AG, Basel
  Introduction
    Since the publication of the results of the NINDS recombinant tissue plasminogen ac-
tivator (rt-PA) Stroke Trial in December 1995   [1]   and US Food and Drug Administration 
approval in June 1996, a substantial effort has been undertaken at both the national and re-
gional level to increase the proportion of patients with ischemic stroke who receive throm-
bolysis, including a relatively new ‘drip-and-ship’ strategy. ‘Drip and ship’ is a term used to 
identify patients in whom intravenous (IV) rt-PA is initiated at the emergency department 
(ED) of a community hospital, followed by transfer within 24 h to a comprehensive stroke 
center. A new International Classification of Diseases, 9th revision, Clinical Modification 
(ICD-9-CM), diagnosis code V45.88, was approved by the Centers for Medicare and Med-
icaid Services on October 1, 2008, to identify patients treated by the ‘drip-and-ship’ para-
digm. Several studies have reported single center experiences with the drip-and-ship para-
digm and provided comparative outcomes with patients treated at primary ED arrival  [2–4] . 
However, no population-based study has evaluated the results of this paradigm in general 
practice.
    There are reasons to believe that the results of ‘drip-and-ship’ treatment may not be as 
promising as reported in single center studies. Single centers may have a well-developed re-
lationship with referring EDs with protocol sharing and real-time assistance through tele-
phone or video conferencing   [5]  . There is also a sampling bias influenced by the population 
served by the study center which may yield different results due to variations in acute inter-
ventions within population groups  [6] . A population-based study is more likely to reflect the 
heterogeneity of implementation by various practices and the study sample is more reflective 
of various racial/ethnic and socioeconomic population groups. 
  M e t h o d s
    The population of the state of Minnesota (225,171 km  2 ) in 2009 according to the census 
was 5,266,214 persons. Whites and African Americans form 87 and 5% of the population, 
respectively; 4% were categorized as persons of Hispanic or Latino origin   [7]  . Thirteen per-
cent of the population is aged   6  65 years and 50% of the overall population is female. 
  The Minnesota Hospital Association (MHA) is a trade association representing 148 hos-
pitals in Minnesota. Under agreement with the Minnesota Department of Health, MHA 3
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serves as the voluntary, nonprofit reporting organization for the collection of the Health 
Care Cost Information System hospital-specific financial, utilization, staffing and service 
data. The data are required by Minnesota Statutes Section 144.695–144.703 and Minnesota 
Rules, chapter 4650, and are a database of key hospital indicators maintained for compara-
tive reporting. There are   1  500 data elements in the database   [8]  . Since 1993, the data are 
based on the Uniform Bill, 1992 version (UB-92). The MHA database is de-identified, which 
is an exemption for institutional review board review. In 1995, the database was expanded to 
invite all Minnesota acute care hospitals to submit data on both in- and outpatient claims on 
a voluntary basis. All standard administrative data elements were collected, including ad-
mission and discharge dates, admission source, discharge type, age, sex, ICD-9-CM diagno-
sis codes with present-on-admission modifiers and ICD-9-CM procedure codes with date 
procedures performed.
    We analyzed the MHA public use data files from October 2008 to December 2009. We 
used the ICD-9-CM   [9]   as primary or secondary diagnosis codes to identify the patients ad-
mitted with ischemic stroke. Diagnostic code fields were screened for specific codes to iden-
tify patients with ischemic stroke using ICD-9 codes 433, 434, 436, 437.0, and 437.1 as pri-
mary or secondary discharge diagnoses. Patients who were assigned the drip-and-ship code 
(ICD-9-CM V45.88 code) were classified as receiving treatment using the drip-and-ship par-
adigm. Patients receiving thrombolysis (identified by ICD-9-CM procedure code 99.10) 
without drip-and-ship code were classified as primary ED arrival. If thrombolysis was ad-
ministered to patients with ICD-9-CM secondary diagnosis codes to identify those with 
stroke-associated complications such as pneumonia (481, 482.3, 482.8, or 486), urinary tract 
infection (590.9 or 599.0), sepsis (038, 995.91, 995.92, 996.64, or 999.3), deep venous throm-
bosis (451.1, 451.2, 451.81, 451.9, 453.1, 453.2, 453.8, or 453.9), pulmonary embolism (415.1), 
intracerebral (ICH) or subarachnoid hemorrhage (430, 431, or 432), and acute myocardial 
infarction (410). We also used ICD-9-CM procedure codes to estimate the percentage of 
stroke patients who underwent stroke-related procedures such as cerebral angiography 
(88.41), carotid angioplasty/stent placement (00.63/00.64), intracranial angioplasty/stent 
placement (00.62/00.65), gastrostomy (43.11–43.19), tracheostomy (31.10, 31.20, 31.21, or 
31.29), and carotid endarterectomy (38.12). We also determined the rate of admission to a 
certified stroke center (14 centers are certified by the Joint Commission in Minnesota) as fi-
nal destination of acute hospitalization in both groups. 
    We also ascertained the following variables between the two groups: age, sex, length of 
hospitalization, discharge status [categorized into home (routine), home health care, short-
term hospital, other long-term facilities including intermediate care and skilled nursing 
home, or death], and medical complications: procedures performed and total cost of hospi-
talization. We used the      2  test for categorical data and analysis of variance for continuous 
data to detect any significant differences in variables among patients treated with IV rt-PA 
either as primary ED arrival mode or using the drip-and-ship paradigm. 
  R e s u l t s
    There were 21,024 admissions for ischemic stroke in Minnesota-based hospitals. Of 
these admissions, 602 (2.86%) underwent treatment with IV rt-PA. Of these 602 patients, 473 
received thrombolysis through primary ED arrival and 129 received thrombolysis through 
the drip-and-ship paradigm. IV rt-PA was administered in 30 hospitals and 13 of them used 
the drip-and-ship paradigm; the number of patients treated with the drip-and-ship para-
digm varied from 1 to 40 between the 13 hospitals. More than half of the patients treated 
with the drip-and-ship paradigm were admitted to 2 hospitals (37 and 40 patients). The rate 4
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of admission to a certified stroke center as final destination for acute hospitalization was 
higher in patients treated with the drip-and-ship paradigm compared with those treated by 
primary ED arrival mode (p = 0.015).   Table 1   demonstrates the demographic and clinical 
characteristics of the patients according to the treatment used. The mean age was similar 
between the two groups. The rates of medical complications appeared to be similar between 
the two patient groups. The rates of additional procedures including cerebral angiography, 
mechanical ventilation, gastrostomy, and carotid or intracranial stent placement were simi-
lar between the two patient groups. 
    The mean length of hospitalization (  8   SD) was 5.98 (  8  4.8) versus 5.11 (   8  3.7) days 
among patients treated with IV rt-PA through primary ED arrival or the drip-and-ship par-
adigm, respectively (  table 2  ). The rates of secondary ICH or subarachnoid hemorrhage were 
higher in patients treated with IV rt-PA through primary ED arrival compared with those 
treated with the drip-and-ship paradigm (8.5 vs. 3.1, respectively; p = 0.038). The in-hospital 
mortality rate was similar among ischemic stroke patients receiving IV rt-PA through pri-
mary ED arrival or through the drip-and-ship paradigm (5.9 vs. 7.0%, respectively). The rate 
of discharge to home following hospitalizations was similar between patients receiving IV 
rt-PA through primary ED arrival or the drip-and-ship paradigm (31.9 vs. 34.9%, respec-
tively). The mean hospital charges were USD 65,669 for primary ED arrival and USD 47,850 
for the drip-and-ship-treated patients (p   !   0.001). 
  Table  1.    Demographic and clinical characteristics of the patients treated with thrombolysis through pri-
mary ED arrival or the drip-and-ship paradigm (MHA data: October 2008 to December 2009)
  Primary ED arrival    Drip-and-ship paradigm     p value 
 Patients,  n  473  129 
  Women  226 (47.8%)  60 (46.5%)    0.798 
 Mean  age  8 SD, years     69.72815.9   71.69813.6   0.201 
  Final destination for acute hospitalization 
  Uncertified center  66 (13.9%)  8 (6.2%)    0.015 
  Certified stroke center1  407 (86.1%)  121 (93.8%) 
 Medical  complications 
  Subarachnoid hemorrhage/ICH  40 (8.5%)  4 (3.1%)    0.038 
  Myocardial infarction  18 (3.8%)  1 (0.8%)    0.092 
  Pneumonia  25 (5.3%)  3 (2.3%)    0.236 
  Urinary tract infection  51 (10.8%)  14 (10.9%)    0.982 
  Sepsis  10 (2.1%)  0 (0%)    0.130 
  Pulmonary embolism  7 (1.5%)  1 (0.8%)    1.000 
  Deep venous thrombosis   3 (0.6%)  1 (0.8%)    1.000 
 Procedures 
  Cerebral angiography  137 (29%)  41 (31.8%)    0.534 
  Mechanical ventilation  11 (2.3%)  1 (0.8%)    0.234 
  Gastrostomy  20 (4.2%)  9 (7.0%)    0.196 
  Tracheostomy  4 (0.8%)  1 (0.8%)    1.000 
  Carotid angioplasty/stent placement   11 (2.3%)  2 (2.6%)    0.591 
  Intracranial angioplasty/stent placement  8 (1.7%)  3 (2.3%)    0.634 
  N  one of the patients was treated with carotid endarterectomy. SD = Standard deviation; ICA = intra-
cerebral hemorrhage.
  1 Certified by the Joint Commission. 
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  Discussion
    In this statewide data set, we found similar outcomes for patients treated with intrave-
nous thrombolysis either after primary ED arrival or through the drip-and-ship paradigm, 
in agreement with results derived from single center studies  [2–4] . Of these 602 patients who 
received IV rt-PA in Minnesota, 473 and 129 patients were treated through primary ED ar-
rival and the drip-and-ship paradigm. A proportion of the 129 patients who received IV rt-
PA through the drip-and-ship paradigm may not have received IV rt-PA without availabil-
ity of this treatment method. The proportion of these patients would be higher in states 
where the Emergency Medical Services transport patients to the nearest available ED in the 
absence of preexisting designated hospital EDs for acute stroke patients. In addition, patients 
treated with the drip-and-ship paradigm were more likely to be admitted to a certified stroke 
center as the final destination for acute hospitalization. The strategy appeared to be cost-
effective in our analysis, but the hospital charges are confounded by the fact that IV rt-PA 
was administered at the originating hospital but the patient is admitted to the receiving hos-
pital. DRG 559 cannot be utilized by the receiving hospital because no thrombolytic agent 
was administered at the receiving hospital. Thus the hospital charges may not account for 
added costs associated with the initial care of patients receiving the thrombolytic agent. 
    The comparable outcomes seen in patients treated with the drip-and-ship paradigm in 
our study are presumably attributable to the ability of ED physicians to identify stroke pa-
tients who are candidates for IV rt-PA with or without expedient consultation with the stroke 
team of the receiving hospital. One study  [10]  compared assessment of eligibility for IV rt-PA 
by ED physician and stroke neurology physician in a sample of patients presenting with pos-
sible stroke symptoms. Agreement with the stroke neurologist for IV rt-PA eligibility was 
93% when compared with the ED physician. In another study   [4]  , the accuracy of ischemic 
stroke diagnosis (by radiographic confirmation) was similar between patients receiving IV 
rt-PA through primary ED arrival or the drip-and-ship paradigm. Rapid acquisition of CT 
scan images at referring EDs and remote expert interpretation have also favorably impacted 
the drip-and-ship paradigm  [11] . Many referral hospitals initiate IV rt-PA using telemedicine 
or telephone consultation before transferring patients to a regional stroke center and, there-
fore, acquire guidance from stroke specialists in a time-efficient manner. In an analysis of 
selected data from the Get-with-the-Guidelines initiative   [5]  , 13 of the 33 referral hospitals 
had an established telemedicine connection with the hospital during the study period; the 
remainder used the telephone. Among the 181 drip-and-ship cases in the study, supervision 
  Table 2.    In-hospital outcomes of the patients treated with thrombolysis through primary ED or the drip-
and-ship paradigm (MHA data: October 2008 to December 2009)
  Primary ED arrival    Drip-and-ship paradigm  p value 
 Patients,  n  473  129 
  Home (routine)  151 (31.9%)  45 (34.9%)  0.525 
  Home health care  26 (5.5%)  4 (3.1%)  0.363 
  Short-term hospital  117 (24.7%)  32 (24.8%)  0.987 
  Long-term facilities  150 (31.7%)  39 (30.2%)  0.787 
  In-hospital mortality  28 (5.9%)  9 (7.0%)  0.658 
  Not stated/missing   1 (0.2%)  0 (0%)  0.601 
 Hospitalization 
 Mean  length8SD, days    5.9884.8   5.1183.7  0.872 
 Charges,  USD   65,669   47,850   <0.001 
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of thrombolysis was by telestroke in 84 (46.4%) and telephone in 97 (53.6%) patients. Televi-
deo consultation increased the accuracy of decision and rate of rt-PA administration in 1 
randomized trial   [12]  . 
  Our study supports the recommendations of various professional organizations that the 
drip-and-ship paradigm of rt-PA administration for stroke may be an effective option for 
increasing the utilization of IV rt-PA in the United States. The American Stroke Association’s 
Task Force on the Development of Stroke Systems   [13]   recommended that ‘a stroke system 
must develop strategies that incorporate hospitals that do not intend to seek stroke center 
status. All hospitals and facilities that could be involved in the care of acute stroke patients 
should develop action plans for the triage and treatment (or transport) of stroke patients’. 
The drip-and-ship paradigm is consistent with the goal of the task forces to ensure that sus-
pected stroke patients should receive timely acute primary stroke care at any hospital in the 
stroke system according to a prespecified care plan. The extensive area that can be covered 
through the drip-and-ship paradigm is highlighted by analyses of the regional hospital 
stroke referral network surrounding Saint Luke’s Hospital Stroke Center in Kansas City   [2]   
and of the University of Texas-Houston Health Science Center   [4]  . These studies found that 
the referring hospitals participating in the drip-and-ship paradigm can range in distance 
from 160 to 650 km from the receiving hospital. 
    The accuracy of our analysis depended upon the accuracy of ICD-9-CM codes V45.88 
and 99.10 on UB-92 summaries. In anticipation of such studies, we had recently studied the 
accuracy of the new V45.88 code for identifying ischemic stroke patients who meet the cri-
teria for the drip-and-ship paradigm at 2 of the participating hospitals in Minnesota  [14] . Out 
of a total of 428 patients discharged from both hospitals with a diagnosis of ischemic stroke, 
37 patients were given ICD-9-CM code V45.88. The internally validated data from the pro-
spective stroke database maintained at these 2 hospitals demonstrated that a total of 40 pa-
tients met the criteria for the drip-and-ship paradigm. A concurrent comparison found that 
92% (sensitivity) of the patients treated with the drip-and-ship paradigm were coded with 
V45.88. None of the non-drip-and-ship stroke cases received the V45.88 code (100% specific-
ity). The positive predictive value of V45.88 was 100%. Previously, we had also studied   [15]   
the accuracy of ICD-9 procedure code 99.10 for use of thrombolysis in ischemic stroke by 
comparing procedure codes of University Hospital discharge data with a concurrent pro-
spective registry. The procedure code 99.10 was designated for injection or infusion of throm-
bolytic agents permitting estimation of national and statewide use in 1998  [16] . The sensitiv-
ity and specificity for ICD-9 procedure code 99.10 in our study was 55 and 98%, respectively. 
The high specificity of both codes suggests that the patient designation for each category is 
most likely accurate, although the exact prevalence may be underestimated   [14, 15, 17]  .
    We used the data from the MHA, a large data set designed to be representative of the 
Minnesota state population. One disadvantage of the MHA database is that it provides 
minimal clinical details on the severity of patients’ neurological deficits, on diagnostic study 
results, or on patients’ medications. We also acknowledge the limitations with case ascer-
tainment using such methodology  [14, 15, 17] . To avoid missing any patients who underwent 
thrombolysis, we included all patients with ICD-9-CM codes for ischemic stroke either as 
primary or secondary discharge diagnoses. A previous study   [18]   indicated that studies 
which use primary and secondary ICD-9-CM discharge codes to measure stroke occur-
rence will overestimate the number of hospitalized strokes in the population. The over-
estimation of the denominator for the derivation of 2.9% rt-PA utilization rate is likely
to underestimate the actual rate of utilization. The denominator did not adjust for the
time interval between symptom onset and admission (including a large proportion of
non-candidates), in-hospital strokes, or multiple admissions of the same patient, which fur-
ther confound the estimate of IV rt-PA use. ICH identified using ICD-9-CM codes in our 7
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study represents all types of ICH (symptomatic and asymptomatic) throughout hospitaliza-
tion and therefore the rates cannot be compared to studies that provide rates of symptom-
atic ICH within the first 24–36 h. The differential rate between ICHs in the two patients 
groups in our study raises the possibility that referring EDs are selecting patients with more 
favorable characteristics for IV rt-PA compared with EDs of receiving hospitals thus result-
ing in better outcomes, lower costs, and lower rates of ICH in patients treated by the drip-
and-ship paradigm.
    The results of the drip-and-ship paradigm compare favorably with IV rt-PA treatment 
through primary ED arrival in this statewide study supporting broader applicability of this 
strategy.
  Acknowledgments/Disclosure  Statement
    Dr. Qureshi has received funding from the National Institutes of Health RO1-NS44976-
01A2 (medication provided by ESP Pharma), American Heart Association Established In-
vestigator Award 0840053N, National Institute of Health U01-NS062091-01A2, and the Min-
nesota Medical Foundation, Minneapolis, Minn. 
 References 
    1  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Dis-
orders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;    333:    1581–1587.
      2  Rymer MM, Thurtchley D, Summers D: Expanded modes of tissue plasminogen activator delivery 
in a comprehensive stroke center increases regional acute stroke interventions. Stroke 2003;    34:e58–
e60.
     3  Silverman IE, Beland DK, Chhabra J, McCullough LD: The ‘drip-and-ship’ approach: starting IV 
t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. Conn 
Med 2005;    69:    613–620.
      4  Martin-Schild S, Morales MM, Khaja AM, Barreto AD, Hallevi H, Abraham A, Sline MR, Jones E, 
Grotta JC, Savitz SI: Is the drip-and-ship approach to delivering thrombolysis for acute ischemic 
stroke safe? J Emerg Med 2011;    41:    135–141.
      5  Pervez MA, Silva G, Masrur S, Betensky RA, Furie KL, Hidalgo R, Lima F, Rosenthal ES, Rost N, 
Viswanathan A, Schwamm LH: Remote supervision of IV-tPA for acute ischemic stroke by telemed-
icine or telephone before transfer to a regional stroke center is feasible and safe. Stroke 2010;    41:e18–
e24.
    6  Gregory PM, Rhoads GG, Wilson AC, O’Dowd KJ, Kostis JB: Impact of availability of hospital-based 
invasive cardiac services on racial differences in the use of these services. Am Heart J 1999;    138:    507–
517.
      7  Minnesota QuickFacts from the US Census Bureau. http://quickfacts.Census.Gov/qfd/states/27000.
html (last accessed on December 17, 2010). 
     8  The Minnesota Hospital Association. http://www.Mnhospitals.Com/index/abouthosp2 (last ac-
cessed on December 17, 2010). 
      9  National Center for Health Statistics: International Classification of Diseases, Ninth Revision, Clin-
ical Modification. Atlanta, Centers for Disease Control and Prevention, 1980.
    10  Mecozzi AC, Brown DL, Lisabeth LD, Barsan WG, Silbergleit R, Hickenbottom SL, Scott PA, Mor-
genstern LB: Determining intravenous rt-PA eligibility in the emergency department. Neurocrit 
Care 2007;    7:    103–108.
  11  Shuaib A, Khan K, Whittaker T, Amlani S, Crumley P: Introduction of portable computed tomogra-
phy scanners, in the treatment of acute stroke patients via telemedicine in remote communities. Int 
J Stroke 2010;    5:    62–66.8
Cerebrovasc Dis Extra 2012;2:1–8
 DOI:  10.1159/000335097 
EXTRA
  Qureshi et al.: rt-PA: Drip-and-Ship Paradigm 
www.karger.com/cee
    © 2012 S. Karger AG, Basel
  Published online: January 10, 2012      
    12  Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, Thomas RG, Lyden PD: Efficacy of site-
independent telemedicine in the STRoke DOC Trial: a randomised, blinded, prospective study. Lan-
cet Neurol 2008;    7:    787–795.
  13  Schwamm LH, Pancioli A, Acker JE 3rd, Goldstein LB, Zorowitz RD, Shephard TJ, Moyer P, Gorman 
M, Johnston SC, Duncan PW, Gorelick P, Frank J, Stranne SK, Smith R, Federspiel W, Horton KB, 
Magnis E, Adams RJ: Recommendations for the establishment of stroke systems of care: recommen-
dations from the American Stroke Association’s Task Force on the Development of Stroke Systems. 
Stroke 2005;    36:    690–703.
    14  Tonarelli SB, Tibbs M, Vazquez G, Lakshminarayan K, Rodriguez GJ, Qureshi AI: Accuracy of the 
new ICD-9-CM code for ‘drip-and-ship’ thrombolytic treatment in patients with ischemic stroke. J 
Stroke Cerebrovasc Dis 2010, E-pub ahead of print.
  15  Qureshi AI, Harris-Lane P, Siddiqi F, Kirmani JF: International classification of diseases and current 
procedural terminology codes underestimated thrombolytic use for ischemic stroke. J Clin Epide-
miol 2006;    59:    856–858.
  16   International classification of diseases and current procedures. http://www.Cms.Gov/paymentsystems/
icd9/fyadde.Pdf (last accessed on December 17, 2010). 
    17  Goldstein LB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic 
stroke: effect of modifier codes. Stroke 1998;    29:    1602–1604.
    18  Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla 
R: The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total inci-
dence rates of stroke among blacks. Stroke 1998;    29:    415–421.
  
 